GLP-1 RAs showed trends toward improvements in endocrine and metabolic, cardiovascular, renal, and respiratory outcomes, cognitive function, with a potential reduction in fracture risk and all-cause mortality in certain populations
What Happens When You Stop Taking GLP-1 Treatments When GLP-1 receptor agonist therapy is discontinued, patients typically experience a reversal of the therapeutic effects that the medication provided
In recent in vivo and in vitro studies, GLP-1 presents a novel therapeutic approach against NAFLD by increasing fatty acid oxidation, decreasing lipogenesis, and improving hepatic glucose metabolism
physicians must be vigilant for signs of pancreatitis and monitor kidney function among people taking GLP-1RA medications
P.BartonD.HullD.ParkerR.et al (2016)
Almandoz JP, Wadden TA, Tewksbury C, et al